Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 21, Issue 9, 1998, Pages 943-946

  Fouillard, L ^a   Deconinck, E ^b   Tiberghien, P ^b   Deschaseaux, M L ^b   Solary, E ^c   Mugneret, F ^c   Brion, A ^b   Herve, P ^b   Cahn, J Y ^b,d  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c HÔPITAL DU BOCAGE   (France)

^d NONE   (France)

Author keywords

Bone marrow transplantation; Chronic myelogenous leukemia; Endogenous recovery; Graft failure; Remission

Indexed keywords

BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; CYTARABINE; MELPHALAN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW RESCUE; CANCER REGRESSION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; GENE REARRANGEMENT; GRAFT FAILURE; HEMATOPOIESIS; HLA MATCHING; HUMAN; MALE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0031938131     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701213     Document Type: Article

References (25)

1. Snyder DS, Negrin RS, O'Donnell MR et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood 1994; 84: 1672-1679.
2. Talpaz M, Kantarjian HM, McCredie KB et al. Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood 1987; 69: 1280-1288.
3. Hoyle C, Gray R, Goldman J. Autografting for patients with CML in chronic phase: an update. Br J Haematol 1994; 86: 76-81.
4. Reiffers J, Goldman J, Meloni G et al. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-410.
5. McGlave PB. Therapy of chronic myelogenous leukemia with related or unrelated donor bone marrow transplantation. Leukemia 1992; 6: (Suppl. 4) 115-117.
6. Cahn JY, Bordigoni P, Souillet G et al. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Bone Marrow Transplant 1991; 1: 1-4.
7. Podesta M, Piaggio G, Frassoni F et al. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytapheresis collected during early recovery after chemotherapy for chronic myeloid leukemia (CML). Bone Marrow Transplant 1995; 16: 549-555.
8. Carella AM, Podesta M, Frassoni F et al. Collection of normal blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-271.
9. Hughes T, Brito-Babapulle F, Marcus RE. Transient Ph-negativity after autografting with blood-derived stem cells for patients with chronic myeloid leukemia in chronic phase. Bone Marrow Transplant 1989; 4 (Suppl. 1): 51.
10. Haines ME, Goldman JM, Worsley AM et al. Chemotherapy and autografting for chronic granulocytic leukemia in transformation; probable prolongation of survival for some patients. Br J Haematol 1984; 58: 711-721.
11. Reiffers J, Trouette R, Marit G et al. Autologous blood stem cells transplant for chronic granulocytic leukemia in transformation: a report of 47 cases. Br J Haematol 1991; 77: 339-345.
12. Gorin NC, Najman A, Vann den Akker J et al. Disappearance of Philadelphia chromosome after autologous bone marrow transplantation for treatment of chronic myeloid leukemia in acute crisis. Lancet 1982; 1: 44.
13. Bergamashi G, Podesta M, Frassoni F et al. Restoration of normal polyclonal haemopoiesis in patients with chronic myeloid leukaemia autografted with Ph-negative peripheral stem cells. Br J Haematol 1994; 87: 867-870.
14. Coulombel L, Kalousek DK, Eaves CJ et al. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New Engl J Med 1983; 308: 1493-1498.
15. Barnett M, Eaves CJ, Phillips GL et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 1994; 84: 724-732.
16. Kantarjian HM, O'Brien S, Anderli P et al. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069-3081.
17. Branch DR, Gallanger MT, Forman SJ et al. Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia. Transplantation 1982; 34: 226-228.
18. Suttorp M, Schmitz N, Prange E et al. Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3. Leukemia 1991; 5: 723-725.
19. Baranov AE, Selidovkin GD, Butturini A et al. Hematopoietic recovery after 10-Gy acute total body radiation. Blood 1994; 83: 596-599.
20. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 241-252.
21. Kolb HJ, Schattenberg A, Goldman JM et al for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
22. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-1268.
23. Porter DL, Roth MS, McGarigle C et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New Engl J Med 1994; 330: 100-106.
24. Morgan GJ, Wieddemann LM. The clinical application of molecular techniques in Philadelphia-positive leukaemia. Br J Haematol 1992; 80: 1-5.
25. Kolb HJ, Mittermüller J, Holler E et al. Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia. Bone Marrow Transplant 1996; 17: 449-452.